How much does a package of 60 tablets of Apremilast cost, and the latest price

Apremilast is an oral drug targeting chronic immune diseases. It is mainly used for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. It selectively inhibits PDE4 enzyme activity, regulates the expression of inflammatory cytokines, reduces skin inflammation and joint pain, and provides patients with a non-injectable treatment option. Its mechanism of action is unique. Compared with traditional immunosuppressants, it can not only improve inflammation, but also reduce the risk of adverse reactions common to some immunosuppressive drugs.

In China, Apremilast has been officially launched and included in the scope of medical insurance, and patients can purchase it through local hospital pharmacies. The common specifications on the market are60 tablets, suitable for a standard treatment course of one or two months. Compared with overseas markets, the domestic price is relatively low due to the medical insurance reimbursement policy, which improves the accessibility and compliance of long-term medication.

In overseas markets, the original drug of Apremilast is available in European and North American versions. The price of the European version is generally more than 10,000 yuan, which is very expensive. It is mainly affected by the cost of the original research and the differences in the international medical insurance system. In addition, there are also generic Apremilast drugs on the market in places such as India and Laos. These generic versions have the same ingredients as the original drug, but the price is only a few hundred yuan, making them an affordable choice for some overseas patients.

It needs to be emphasized that different versions of apremilast are basically consistent in efficacy, but patients should still give priority to doctor's prescriptions and formal channels when using it to avoid drug safety risks caused by informal channels. Overall, Apremilast tablets not only play an important role in the treatment of psoriasis and psoriatic arthritis, but its domestic medical insurance coverage and diversified overseas supply also provide patients with flexible medication options, making it an important oral drug in the management of chronic immune diseases.

Reference materials:https://go.drugbank.com/drugs/DB05676